300Microns

300Microns

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

300MICRONS is a specialized tools and consumables company focused on the high-growth 3D cell culture market. Its core technology involves microscale thermoforming of thin, transparent polymer films into microwell arrays with unique round bottoms, which can be further functionalized with pores or surface modifications. The company serves both academic and industrial customers in drug discovery, toxicity testing, and tissue engineering through standard products and custom OEM solutions. As a private SME, it operates in a competitive but expanding niche critical for advancing more physiologically relevant in vitro models.

Drug DeliveryMedical Devices

Technology Platform

Proprietary microscale thermoforming of thin polymer films to create microwell arrays for 3D cell culture. Platforms can be functionalized with ion track-etched micropores, nanotopographies, and adhesive patches to control the cellular microenvironment.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The global shift towards more predictive 3D cell culture and organ-on-a-chip models in drug discovery creates strong demand for advanced scaffold technologies.
The company's OEM model allows it to embed its proprietary microwell arrays into other platforms, providing a scalable B2B revenue stream alongside direct product sales.

Risk Factors

Faces competition from large, established life science tools companies and other niche players in the 3D culture space.
As a small SME, it carries risks associated with scaling manufacturing, market adoption of its specialized technology, and potential dependence on a limited number of key customers or OEM partners.

Competitive Landscape

Competes in the 3D cell culture consumables market against giants like Corning (Elplasia plates), Merck (Ultra-Low Attachment plates), and Greiner Bio-One, as well as specialized firms like MicroTissues (now part of Sigma-Aldrich) and Insphero. Differentiates through its unique round-bottom, ultra-thin film design and exclusive porous microwell technology.